2020 Annual Demographic Survey of Parkinson’s Disease and Movement Disorder Nurse Specialists by Williams, Susan et al.
Australasian Journal of Neuroscience  Volume 31 ● Number 1 ● May 2021 
 15 
Introduction 
In Australia, it is estimated that 80,000 peo-
ple are living with Parkinson’s disease 
(Rossiter et al., 2019).  The median time 
from disease onset to death is approximate-
ly 12.4 years, with many living with the dis-
ease for over 20 years (Deloitte, 2015). A 
significant proportion of people living with 
Parkinson’s disease suffer from disabilities 
that require long term care (Williams et al., 
2017) with an estimated average lifetime 
financial cost of $161,300 per patient over 
the 12 years.  In 2018, the estimated total 
economic cost was $12.3 billion (Deloitte, 
2015).   
 
A person living with Parkinson’s disease 
may experience a collection of motor and 
non-motor symptoms which are specific to 
the individual.  The cardinal motor symp-
toms of PD include tremor, rigidity, akinesia 
or bradykinesia and postural stability along 
with many others.  However, the non-motor 
symptoms of Parkinson’s disease are often 
more troublesome as it is less visible and is 
often a neglected aspect of the condition.  
Common non-motor symptoms may include 
mood and sleep disturbances, autonomic 
dysfunction and cognitive impairment 
(Durcan et al., 2019).   
 
The management of Parkinson’s disease 
and the varying combination of all its com-
plex symptoms require expert titration of 
medications and psychosocial interventions 
to achieve a balance that will provide pa-
tients with quality of life.  In order to execute 
this with precision, the need for Parkinson’s 
disease and movement disorder nurse spe-
cialists (PDMDNS) is warranted (Bramble et 






Parkinson’s disease  is the second most common neurological disorder after dementia in Austral-
ia (Deloitte, 2015).  The complexities of caring for a person with Parkinson’s disease highlights 
the need for Parkinson’s disease and movement disorder nurse specialists (PDMDNS) (Bramble, 
Carroll, & Rossiter, 2018).  
 
The Australasian Neuroscience Nurses Association’s (ANNA) Movement Disorder Chapter (MDC) 
aims to implement an annual demographic survey over the next 10 years to capture the charac-
teristics of the PDMDNS cohort, identify gaps in service provision and aid the workforce planning 
through useful and influential data.   
 
The results of this survey were able to highlight the geographical areas that are underserviced, 
the diverse employment opportunities available and the issues around financial funding for 
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It has long been recognized that PDMDNS 
provide skilled clinical care, education and 
advice through communication with pa-
tients, carers and health care providers. 
These interventions reduce both physical 
and psychological morbidity and result in 
improved health outcomes (MacMahon & 
Thomas, 1998). 
 
In Australia, the role of the PDMDNS is as 
diverse as the presentation of the condition 
itself. The employment of a Parkinson’s dis-
ease nurse by the Parkinson’s Association 
of Western Australia in 1998, was the first 
published reference recording the start of 
the specialty in Australia (Doherty, 1999).  
However, it is historically believed that the 
first PDMDNS role may have been in estab-
lished as early as 1985 in the setting of a 
hospital based, industry funded, clinical tri-
als nurse.   
This study is the first of a series of annually 
recurring publications to progressively moni-
tor the growth and development of the 
PDMDNS profession over the next ten 
years. This is to provide appropriate evi-
dence to ensure the PDMDNS in Australia 
are supported with adequate resources, 
sufficient training and appropriate levels of 
qualifications.  It will also assist in identifying 
the gaps in the profession as well as the 
provision of service to people living with 
Parkinson’s disease. 
Study Objectives 
The primary objective was to collect demo-
graphic information pertaining to PDMDNS 
positions in Australia including the popula-
tion, the geographic location, the level of 
education and the clinical experience of the 
nurses.  It was also aimed to explore the 
nature of work that the PDMDNS are en-
gaged in and the long-term sustainability of 
this subspecialised nursing workforce.   
 
The secondary objectives were to analyse 
data to identify gaps in service provision to 
people living with Parkinson’s disease in 
Australia. This information will aid in work-
force planning related to funding, education 





The study and its design were initiated sole-
ly and independently by the Australasian 
Neuroscience Nurses Association (ANNA) 
Movement Disorder Chapter (MDC) with no 
financial funding and/or conflict of interests. 
The ethics application was submitted to and 
approved by Northern Sydney Local Health 
District Human Research Ethics Committee 
2019/ETH12872: Parkinson's Disease 
Movement Disorder Nurse Specialist Demo-
graphic Survey as a low or negligible risk 
project. 
 
Data was collected through an anonymous 
online multiple choice survey produced us-
ing the website https://
www.surveymonkey.com. The survey in-
cluded a series of quantitative, multiple 
choice questions designed to sample a co-
hort of PDMDNS across all states in Aus-
tralia, including years of service, employer 
types and levels of education.  This survey 
was emailed to 100 PDMDNS contacts 
known to the ANNA MDC but only the recip-
ients who were employed as a specialty 
nurse working directly with people with 
Parkinson’s in Australia were included.    
Study Results  
Between 21st April 2020 and 20th May 
2020, we distributed a total of 100 surveys 
and received 70 responses.  87% (n=61) 
met the inclusion criteria and were ana-
lysed.   
On examination of the 61 specialised 
PDMDNS positions, New South Wales and 
Victoria held the highest population with 
31% (19) in New South Wales, 26% (16) in 
Victoria, 18% (11) in Queensland, 10% (6) 
in Western Australia, 8% (5) in South Aus-
tralia, 5% (3) in Tasmania and 2% (1) in the 
Australian Capital Territory. There was no 
PDMDNS position employed in the Northern 
Territory (Figure 1). 
New South Wales employed 12 metropoli-
tan, 5 regional and 2 rural positions. Victoria 
had 12 metropolitan, 2 regional, 2 rural posi-
tions . Queensland had 7 metropolitan, 3 
regional, 1 rural position. Western Australia 
had 5 metropolitan, and 1 rural position. 
South Australia had 4 metropolitan, 1 re-
gional position, Tasmania had 1 metropoli-
tan and 2 regional positions. The only posi-
tion in Australian Capital Territory was em-
ployed in the metropolitan area (Figure 1).  
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Nationally across Australia, the majority of 
the PDMDNS positions were based in the 
metropolitan area at 69% (42) with the re-
maining 21% (13) and 10% (6) located in re-
gional and rural areas respectively (Figure 2).  
 
The largest employer of PDMDNS positions 
was the state Department of Health which 
employed 49% (30) of the positions across 
Australia seconded by the pharmaceutical 
industry with 21% (13) which employ nurses 
as product specialists or support nurses for 
device assisted therapies (Figure 3). Other 
employers include 8% (5) by consumer or-
ganisations, 7% (4) from private practices, 
3% (2) in Primary Health Network, 3% (2) in 
Private Hospitals and 2% (1) in university or 
educational institutions.  There were 20% 
(12) that did not specify their employer as 
their employer may not have been clearly 
represented (Figure 3).   
Workforce Stability 
The permanency of funding indicates 59% 
(36) of PDMDNS are permanently funded 
with 31% (19) of PDMDNS positions without 
permanent funding. There were 10% (6) that 
answered ‘not applicable’ for various reasons 
possibly due to the contractual or perfor-
mance based nature of their position (Figure 
4).   
Levels of Experience 
It was identified that 33% (20) of the 
PDMDNS nurses had 5-10 years’ experience 
in their positions with 26% (16) having held 
their positions for over 10 years.  The third 
most prominent cohort with 25% (15) were 
the nurses with experience between 2-5 
years.   
Work force stability forecasts fairly consistent 
workforce with 33% (20) intending to stay in 
their position for 6-10 years with 16% (10) 
intending to stay 11-15 years and 21% in-
tending to stay for 16-20 years.   
Level of Education 
Within our cohort, 23% (14) recorded a regis-
tered nursing degree as their highest level of 
education related to their nursing position. 
25% (15) have completed a graduate certifi-
cate and the largest group at 30% (18) held a 
graduate diploma.  Those who hold are mas-
ter’s degree account for 21% (13) of the 
group and 2% (1) hold a doctorate. 
Discussion  
The results of this survey were able to identi-
fy three key issues of the PDMDNS work-
force. 
Firstly, we were able to quantify that the rural 
and regional areas are underserviced.  
While  the disparity in the number of nurse 
positions across states and regions was ex-
pected anecdotally, it was useful to objective-
ly quantify the severity of this issue . This 
data may assist local service providers, con-
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sumer groups and professional bodies to ad-
vocate for changes in the health system to 
provide additional funding to ensure this sig-
nificant Parkinson’s patient population in 
those geographical areas has access to this 
specialised nursing care.  
 
Secondly, PDMDNS employed by pharma-
ceutical companies are an integral part of the 
PDMDNS ecosystem.  Although these nurses 
are often viewed with a negative connotation 
due to fears of conflicts of interest, the phar-
maceutical industry is the second largest em-
ployer of PDMDNS and partnership with 
these nurse specialists are an integral part of 
providing specialised nursing care for people 
with Parkinson’s and meeting the gaps in 
service. 
 
Thirdly, and one of the most crucial observa-
tion that was extrapolated from the results of 
this year’s data is the lack of permanent fund-
ing for PDMDNS positions in Australia.  Over 
30% of these PDMDNS positions are current-
ly operating without assurance of permanent 
funding.  There is a high risk that the loss of 
these positions would lead to loss of clinical 
expertise and experience in an extremely 
subspecialised field if more secure funding is 
not sought.  We aim to collect more detailed 
information regarding the temporary funding 
arrangements in future surveys to assist in 
identifying the current limitations in this area. 
 
One limitation of the study included the inabil-
ity to capture  the characteristics of nurses 
who have a special interest in Parkinson’s 
disease and act as a champion in their work-
place but are not employed specifically in a 
specialty position.  These nurses may include 
nurse educators in an aged care or rehabilita-
tion facility, a registered nurse in a ward envi-
ronment or a community nurse providing 
nursing care in a home setting.   Future de-
sign of the survey will maintain consistency in 
recapturing existing data for comparative pur-
poses but will also refine the survey design to 
overcome this limitation.   
 
On an encouraging note, in January 2019, 
the Liberal National Government announced 
$6.8 million over four years for Primary 
Health Networks to improve access to spe-
cialized nursing care in the community for 
people living with movement disorders, in-
cluding Parkinson’s disease (Australian Min-
ister of Health, 2019). Consequently, we an-
ticipate a significant influx of PDMDNS in ru-
ral and regional areas over the next four 
years.  Ultimately, this will improve access to 
specialized care for people living with Parkin-
son’s disease in these previously underserv-
iced areas. With expected growth in 
PDMDNS positions, it is both essential that 
this new group of nurses are educated and 
supported to provide their patients with best 
practice nursing care.  It is also crucial to 
challenge the existing and established group 
of PDMDNS to remain engaged with ongoing 
education, maintain currency of practice and 
be able to provide mentorship to these devel-
oping PDMDNS.   
 
Conclusion 
This Demographic survey is the first of its 
kind and captures a snapshot of the 
PDMDNS workforce in Australia. Collecting 
this information annually will provide infor-
mation on trends and the changing nature of 
these positions over time.   
 
The results of this survey highlighted three 
key issues in the PDMDNS cohort which in-
cluded the underservicing of rural and region-
al areas, the integral role of the pharmaceuti-
cal industry PDMDNS and the significant per-
centage of PDMDNS positions that do not 
have the assurance of permanent funding. 
 
There is a forecast that there will be an influx 
of PDMDNS positions over the next four 
years.  Preparations to educate and upskill a 
growing workforce need to occur now.  The 
nursing, medical and consumer groups need 
to collaboratively lobby for adequate re-
sources from governing bodies to ensure re-
sources are provided to address the needs of 
this growing and vulnerable Parkinson’s pop-
ulation and the group of specialised Parkin-
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